Sign in
Taking people in United StatesNo phase

Thinking and learning skills in people with congenital central hypoventilation syndrome

Measures thinking skills in people with a rare breathing and nervous system disorder.

Key facts

Who runs it
Ilya Khaytin
Where
Chicago, Los Angeles, Philadelphia, and Seattle, United StatesSee the 4 sites
Trial code
Registry title
Neurocognition in Congenital Central Hypoventilation Syndrome (CCHS)
Status
Recruiting
People taking part
1,000 people, planned
Started
Jan 2016
Expected to end
Dec 2035
Type of study
Observational
Treatments tested
  • NIH Toolbox Cognition Battery
Record updated
3 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with congenital central hypoventilation syndrome (CCHS), confirmed by a PHOX2B gene change, who speak and read English. They take a thinking-skills test.

Age
3 Years to 85 Years
Sex
All sexes can join.
Disease stage
CCHS diagnosis confirmed by a PHOX2B mutation.
Biomarker or test result
PHOX2B mutation confirmed.

Main reasons for not taking part

  • CCHS that is only suspected or not confirmed
  • Does not speak or read English as a primary language

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • PHOX2B mutation-confirmed CCHS diagnosis
  • Speaks and reads English as a primary language

Who cannot take part

  • Unsuspected or unconfirmed CCHS
  • Does not speak or read English as a primary language

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 3 and 85 years old?

Where in United States

  • Ann & Robert H. Lurie Children's Hospital of ChicagoChicago, United StatesContact: Casey RandTaking people
  • Children's Hospital Los AngelesLos Angeles, United StatesContact: Iris Perez, MDTaking people
  • Children's Hospital of PhiladelphiaPhiladelphia, United StatesContact: Casey Rand, BSEnrolling by invitation
  • Seattle Children's HospitalSeattle, United StatesContact: Maida Chen, MDTaking people

About the trial

What the trial wants to find out

Congenital central hypoventilation syndrome (CCHS) is a rare disorder of autonomic and respiratory regulation that frequently alters oxygen delivery to the brain. In CCHS, neurocognitive function has been of great concern because of the potential for repeated hypoxemia and hypercarbia in activities of daily living in addition to hypoventilation with related hypoxemia and hypercarbia during sleep. As the world's leading referral center for CCHS, the Center for Autonomic Medicine in Pediatrics (CAMP) is engaged in ongoing research to identify factors that impact neurocognitive performance in patients with CCHS in order to optimize clinical management and improve long term neurocognitive outcomes.

Read full original descriptionShow less

The purpose of this IRB-approved research study is to implement the NIH Toolbox as a standard measurement of cognitive health in patients with CCHS. Further, the study aims to determine how intrinsic and extrinsic disease factors such as age at diagnosis, PHOX2B mutation type and genotype, and nature of past and present artificial respiratory intervention affect the NIH Toolbox Cognitive scores of individuals with CCHS. Eligible participants will complete a 45-minute NIH Toolbox assessment and parents (or adult participants) will complete an associated, 15-minute Research Electronic Data Capture (REDCap) questionnaire.

Treatments tested

  • NIH Toolbox Cognition Battery

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Neurocognitive Outcome as a Metric for Evaluating Therapeutic Intervention and Treatment Mechanisms in Congenital Central Hypoventilation Syndrome (CCHS): A Multi-Site Study Using The NIH Toolbox
Plain-language title
Thinking and learning skills in people with congenital central hypoventilation syndromeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT03568669, who can take part
Record updated
3 September 2026